
Case reports showed encouraging outcomes in eczema, but the company is pursuing deeper validation.

Case reports showed encouraging outcomes in eczema, but the company is pursuing deeper validation.

Bradley Burnam discusses results from an in-vivo model of atopic dermatitis.

Published: August 26th 2025 | Updated: